A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

2018210 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Biology of Blood and Marrow Transplantation

Volume 25, Issue 2, pp. 369-381

Field-Weighted Citation Impact: 17.50